Compared with the exosomes of normoxic CAFs, the exosomes of hypoxic CAFs could target HMGB3 and bcatenin/c-Myc regulatory axis by secreting miR-200b-3p and thus promote the therapeutic effect of 5-FU on CRC in vivo (113). The gene discussed is HMGB3; the disease is colorectal carcinoma.